| Patent Number |
Title Of Patent |
Date Issued |
| 7569383 |
Chimeric flavivirus vectors |
August 4, 2009 |
| The invention provides chimeric flavivirus vectors including foreign peptides inserted into the envelope proteins of the vectors and methods of using these vectors. |
| 7507415 |
West nile virus vaccine |
March 24, 2009 |
| The invention provides chimeric flavivirus vaccines against West Nile virus and methods of using these vaccines to prevent or treat West Nile virus infection. |
| 7459160 |
Chimeric flaviviruses |
December 2, 2008 |
| The invention provides flavivirus vaccines and methods of making and using these vaccines. |
| 7361352 |
Influenza immunogen and vaccine |
April 22, 2008 |
| A chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid (HBc) protein is disclosed that contains an immunogen for inducing the production of antibodies to the influenza M2 protein. An immunogenic influenza sequence in two to four copies is preferably expressed at or nea |
| 7115270 |
Smallpox vaccine |
October 3, 2006 |
| The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines. |
| 6969520 |
Active immunization against clostridium difficile disease |
November 29, 2005 |
| The invention provides active and passive immunization methods for preventing and treating Clostridium difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin, C. difficile toxoids, or combinations thereof. Also pro |
| 6962708 |
Chimeric flavivirus vaccines |
November 8, 2005 |
| A chimeric live, infectious, attenuated virus containing a yellow fever virus, in which the nucleotide sequence for a prM-E protein is either deleted, truncated, or mutated, so that functional prM-E protein is not expressed, and integrated into the genome of the yellow fever virus, a |
| 6878372 |
Methods of preventing and treating flavivirus infection in animals |
April 12, 2005 |
| The invention provides methods of preventing and treating flavivirus infection in animals. |
| 6723325 |
Smallpox vaccine |
April 20, 2004 |
| The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines. |
| 6696281 |
Chimeric flavivirus vaccines |
February 24, 2004 |
| A chimeric live, infectious, attenuated virus containing a yellow fever virus, in which the nucleotide sequence for a prM-E protein is either deleted, truncated, or mutated, so that functional prM-E protein is not expressed, and integrated into the genome of the yellow fever virus, a |
| 6682883 |
Diagnosis of flavivirus infection |
January 27, 2004 |
| The invention provides methods and kits for use in diagnosing flavivirus infection. |
| 6680168 |
Passive immunization against clostridium difficile disease |
January 20, 2004 |
| The invention provides active and passive immunization methods for preventing and treating Clostridium difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin, C. difficile toxoids, or combinations thereof. Also pro |
| 6585975 |
Use of Salmonella vectors for vaccination against helicobacter infection |
July 1, 2003 |
| The invention provides a method of immunization against Helicobacter, involving mucosal administration of an attenuated Salmonella vector including a nucleic acid molecule encoding a Helicobacter antigen, and parenteral administration of a soluble Helicobacter antigen, co-administere |
| 6576244 |
LT and CT in parenteral immunization methods against helicobacter infection |
June 10, 2003 |
| This invention provides methods of inducing a protective or therapeutic immune response to Helicobacter infection in a mammal by parenterally administering to the mammal one or more Helicobacter antigens and an adjuvant selected from one or more of LT, CT, LTB, and CTB. |
